Explorer les evidences

70,7 %70.7% of the female postgraduate students at the University of Ibadan preferred cervical cancer screenings to be done during antenatal clinic visits.

Nigeriacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 6 observations

93,3 %93.3% of the respondents were willing to undergo cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations

Cervical cancer is the second leading cause of female cancer deaths in Nigeria.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations

96,25 %Knowledge of HPV and cervical cancer among senior secondary school aged girls had a mean score of 96.25%.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2022BMC public healthPubMeddocument de 6 observations

24 patientsTwenty-four patients were audited in the retrospective audit of the 3D-HDR-BT pilot program for cervical cancer in Lagos, Nigeria.

Nigeriacancer du col de l'utéruspublié 2025BrachytherapyPubMeddocument de 8 observations

21,6 %Less than one-third (21.6%) of those treated returned for post-treatment screening test.

Nigeriacancer du col de l'utérusobservé October 2020 to July 2021publié 2023Reproductive healthPubMeddocument de 9 observations

2,06 scoreThe mean knowledge of cervical cancer was 2.06±0.55.

Nigeriacancer du col de l'utéruspublié 2020The Pan African medical journalPubMeddocument de 7 observations

4 %Only 4% of the respondents had their daughters vaccinated against HPV.

Nigeriacancer du col de l'utéruspublié 2020The Pan African medical journalPubMeddocument de 5 observations

Cervical cancer is the second highest cause of female cancer deaths in Nigeria.

Nigeriacancer du col de l'utéruspublié 2022BMC public healthPubMeddocument de 6 observations

76,71 %76.71% of the 790 respondents exhibited a high level of knowledge of cervical cancer, its causes, risk factors and prevention.

Nigeriacancer du col de l'utéruspublié 2024African health sciencesPubMeddocument de 5 observations

Invasive cervical cancer (ICC) is a serious public health burden in Nigeria, where human immunodeficiency virus (HIV) remains highly prevalent.

Nigeriacancer du col de l'utérus · VIH/sidapublié 2022Frontiers in public healthPubMeddocument de 4 observations

13,5 %Cervical cancer screening uptake was 13.5% among HIV-seronegative females.

Nigeriacancer du col de l'utéruspublié 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

86 %Most women (86%) had a normal Pap smear at first cervical cancer screening at Jos University Teaching Hospital in Nigeria.

Nigeriacancer du col de l'utéruspublié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

4,5 %4.5% of respondents had ever undergone cervical cancer screening in a community health outreach program in Ituku, Enugu State, Nigeria.

Nigeriacancer du col de l'utérusobservé 2024publié 2026Rural and remote healthPubMeddocument de 8 observations

Women in low- and middle-income countries remain at high risk of developing cervical cancer.

Nigeriacancer du col de l'utéruspublié 2020International journal of health geographicsPubMeddocument de 4 observations

0,346 odds_ratioReligion was an independent predictor of lower brachytherapy utilization (p = 0.003, OR = 0.346, 95% CI = 0.171–0.701).

Nigeriacancer du col de l'utérusobservé March 2021 to June 2024PubMeddocument de 6 observations

77,2 %A majority of respondents (77.2%) had low knowledge of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021JCO global oncologyPubMeddocument de 7 observations

93,3 %93.3% of the 105 surveyed Nigerian gynecologists reported awareness of the SOGON clinical practice guidelines for cervical cancer prevention.

Nigeriacancer du col de l'utéruspublié 2025JMIR cancerPubMeddocument de 8 observations

58,1 %58.1% of the 105 surveyed Nigerian gynecologists reported integrating the SOGON clinical practice guidelines into routine clinical practice.

Nigeriacancer du col de l'utéruspublié 2025JMIR cancerPubMeddocument de 8 observations

45,2 %45.2% of rural women in North Central Nigeria had fair/good knowledge of cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

50,5 %50.5% of the female postgraduate students at the University of Ibadan agreed that the benefits of cervical cancer screening outweigh the stress of the screening procedure.

Nigeriacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 6 observations

3,3 %Cervical cancer screening prevalence among women aged 30–49 years in Nigeria was 3.3% in the North East region.

Nigeriacancer du col de l'utérusobservé 2023–24PubMeddocument de 3 observations

Cervical cancer is the second leading cause of cancer-related deaths among women in Nigeria, after breast cancer.

Nigeriacancer du col de l'utéruspublié 2025Cancer control : journal of the Moffitt Cancer CenterPubMeddocument de 6 observations

Most cervical cancer cases occur in women aged 15–44 years.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

Cervical cancer is a leading cause of cancer deaths among women in Nigeria.

Nigeriacancer du col de l'utéruspublié 2026JMIR formative researchPubMeddocument de 7 observations